Genocea Biosciences Probability of Future Stock Price Finishing Over 2.0E-4
| GNCADelisted Stock | USD 0.0002 0.0001 100.00% |
Genocea |
Genocea Biosciences Target Price Odds to finish over 2.0E-4
The tendency of Genocea Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.0002 | 90 days | 0.0002 | about 73.24 |
Based on a normal probability distribution, the odds of Genocea Biosciences to move above the current price in 90 days from now is about 73.24 (This Genocea Biosciences probability density function shows the probability of Genocea Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Genocea Biosciences has a beta of -26.72. This usually indicates as returns on its benchmark rise, returns on holding Genocea Biosciences are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Genocea Biosciences is expected to outperform its benchmark. In addition to that Genocea Biosciences has an alpha of 87.6719, implying that it can generate a 87.67 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Genocea Biosciences Price Density |
| Price |
Predictive Modules for Genocea Biosciences
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Genocea Biosciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Genocea Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Genocea Biosciences Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Genocea Biosciences is not an exception. The market had few large corrections towards the Genocea Biosciences' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Genocea Biosciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Genocea Biosciences within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 87.67 | |
β | Beta against Dow Jones | -26.72 | |
σ | Overall volatility | 0 | |
Ir | Information ratio | 0.20 |
Genocea Biosciences Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Genocea Biosciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Genocea Biosciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Genocea Biosciences is not yet fully synchronised with the market data | |
| Genocea Biosciences has some characteristics of a very speculative penny stock | |
| Genocea Biosciences has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 1.64 M. Net Loss for the year was (33.2 M) with profit before overhead, payroll, taxes, and interest of 1.64 M. | |
| Genocea Biosciences currently holds about 20.14 M in cash with (45.37 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.34, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Genocea Biosciences Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Genocea Stock often depends not only on the future outlook of the current and potential Genocea Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Genocea Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 68.6 M | |
| Cash And Short Term Investments | 37.1 M |
Genocea Biosciences Technical Analysis
Genocea Biosciences' future price can be derived by breaking down and analyzing its technical indicators over time. Genocea Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Genocea Biosciences. In general, you should focus on analyzing Genocea Stock price patterns and their correlations with different microeconomic environments and drivers.
Genocea Biosciences Predictive Forecast Models
Genocea Biosciences' time-series forecasting models is one of many Genocea Biosciences' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Genocea Biosciences' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Genocea Biosciences
Checking the ongoing alerts about Genocea Biosciences for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Genocea Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Genocea Biosciences is not yet fully synchronised with the market data | |
| Genocea Biosciences has some characteristics of a very speculative penny stock | |
| Genocea Biosciences has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 1.64 M. Net Loss for the year was (33.2 M) with profit before overhead, payroll, taxes, and interest of 1.64 M. | |
| Genocea Biosciences currently holds about 20.14 M in cash with (45.37 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.34, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Consideration for investing in Genocea Stock
If you are still planning to invest in Genocea Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Genocea Biosciences' history and understand the potential risks before investing.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Transaction History View history of all your transactions and understand their impact on performance |